Back to Trades
Total Value
$5.4M
Net $5.4M sold
Filing Date
Jul 17, 2026
7 transactions
Sales
$5.4M
7 transactions
Trade Summary
On Jul 15, 2026 through Jul 17, 2026, Kroeger Christopher A., Insider, sold $5.4M of MapLight Therapeutics, Inc. (MPLT) across 7 transactions. The filing covers Voting Common Stock and reflects net selling of $5.4M. Reported prices ranged from $36.00 to $37.96. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- MapLight Therapeutics, Inc.
- Ticker Symbol
- MPLT
- CIK
- 0001770069
Insider Information
- Role
- Insider
- Location
- REDWOOD CITY, CA
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 15, 2026
- Accession Number
- 0001658918-26-000014
- Form Type
- 4
- Net Trading Amount
- -$5.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 15, 2026 | Voting Common Stock | 18,950 | $36.00 | Sale | $682.2K |
| Jul 15, 2026 | Voting Common Stock | 42,738 | $36.99 | Sale | $1.6M |
| Jul 15, 2026 | Voting Common Stock | 90 | $37.54 | Sale | $3.4K |
| Jul 16, 2026 | Voting Common Stock | 40,899 | $36.46 | Sale | $1.5M |
| Jul 16, 2026 | Voting Common Stock | 28,091 | $37.26 | Sale | $1.0M |
| Jul 16, 2026 | Voting Common Stock | 92 | $37.96 | Sale | $3.5K |
| Jul 17, 2026 | Voting Common Stock | 16,779 | $37.90 | Sale | $635.9K |
Want live alerts when Kroeger Christopher A. trades again?
Download Insider Trades to track MPLT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F7)The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.